| Developers: | N.F. Gamalei National Research Center for Epidemiology and Microbiology |
| Branches: | Pharmaceuticals, medicine, healthcare |
Content |
Main article: Vaccines against COVID-19 coronavirus in Russia
The Sputnik M vaccine is intended for adolescents aged 12 to 17 years.
2021
Vaccine registration
On November 24, 2021, it became known about the registration of COVID-19 the Sputnik M coronavirus vaccine, which is intended for adolescents aged 12 to 17 years.
 | Today, permission has been received to use Sputnik already in the children's population, the vaccine has been registered, we can share this joyful fact, TASS quoted Denis Logunov, deputy director of the Gamalei Center (developer of the drug). |  |
According to the Ministry of Health of the Russian Federation, according to the results of all the necessary clinical studies, during which Sputnik M showed high safety and effectiveness, and on the basis of a positive expert opinion, the department decided to register this vaccine.
A clinical study of a vaccine for adolescents by the end of November 2021 is taking place on the basis of ten clinics and two children's hospitals. A clinical trial of a vaccine for adolescents is taking place on the basis of ten clinics and two children's hospitals.
It is expected that the Sputnik M vaccine will enter civil circulation at the end of December 2021. According to the Ministry of Health, vaccination against coronavirus of adolescents aged 12 to 15 years will be carried out only with the consent of parents or other legal representatives, and from 15 years - only with their own written informed voluntary consent.
Sputnik M vaccination is carried out in two stages, as well as Sputnik V for people over 18 years old, but the vaccine dosage for children is five times less than for adults.
Russian President Vladimir Putin suggested at a meeting to think about creating a vaccine for coronavirus for children from two years old. The National Research Center for Epidemiology and Microbiology named after N.F. Gamalei confirmed that they already have a plan to create such a drug. At the same time, the Sputnik vaccine for children from two years old will most likely be nasal.[1]
Named vaccine side effects for adolescents
On October 25, 2021, at the N.F. Gamalei National Research Center for Epidemiology and Microbiology of the Ministry of Health of Russia, which created the COVID-19 Sputnik V coronavirus vaccine, they talked about the side effects of the drug for adolescents that were identified during clinical trials.
| | In a pediatric vaccine, very minor side effects are an increase in temperature to 37.2-37.3 degrees, "said Alexander Ginzburg, director of the Hamalei Center. | |
He also added that the Sputnik V vaccine for adults is safe for reproductive function, while coronavirus has a negative effect on it. Ginzburg advised Russians who think about the birth of children to be vaccinated.
On September 23, 2021, the Ministry of Health announced that it had received documents from the Gamalei Center for the registration of the COVID-19 vaccine for adolescents. On October 12, Russian Minister of Health Mikhail Murashko said that an expert assessment of the possibility of vaccination against juvenile coronavirus could be completed within the next two weeks.
A study of the drug among adolescents began in early July 2021. It is held To Moscow in on the basis of the Morozov Children's Hospital and the Children's Hospital named after Z.A. Bashlyaeva. As the deputy mayor said, Moscow Anastasia Rakova the children tolerated vaccination well, they did not have serious side effects.
It is assumed that the drug will be called Sputnik M, in which the letter "M" will mean "for the little ones" - by analogy with the anti-tuberculosis vaccine BCG-M, which vaccinates premature newborns.
In mid-June 2021, the World Health Organization (WHO) amended its recommendations advising against vaccinating children against coronavirus. However, almost immediately the opinion was changed: the WHO reported that children need to be vaccinated, but only after the elderly, doctors and people with chronic diseases.[2]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |